Chemoinformaics analysis of 2,6-Dimethyl-2-octene
| Molecular Weight | 140.27 | nRot | 4 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 1 |
| Exact Molecular Weight | 140.156 | nRing | 0 |
| Solubility: LogS | -4.744 | nHRing | 0 |
| Solubility: LogP | 5.088 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.0359 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.521 |
| Synth | 2.778 |
| Natural Product Likeliness | 2.124 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.046 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.301 |
| MDCK | 0.0000162 |
| BBB | 0.728 |
| PPB | 0.972081 |
| VDSS | 4.165 |
| FU | 0.0335754 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.438 |
| CYP2c19-sub | 0.856 |
| CYP2c9-inh | 0.479 |
| CYP2c9-sub | 0.723 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.2 |
| CL | 13.906 |
| T12 | 0.219 |
| hERG | 0.022 |
| Ames | 0.004 |
| ROA | 0.018 |
| SkinSen | 0.728 |
| Carcinogencity | 0.125 |
| EI | 0.983 |
| Respiratory | 0.149 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.93515 |